Twist Bioscience Corporation TWST Proceeds from issuance under employee stock purchase plan
Proceeds from issuance under employee stock purchase plan at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept twst:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan.
The official record: Twist Bioscience Corporation’s 10-K, filed November 17, 2025, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's proceeds from issuance under employee stock purchase plan.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's proceeds from issuance under employee stock purchase plan?
- Twist Bioscience Corporation (TWST) reported proceeds from issuance under employee stock purchase plan of $1.78M in Q3 2025.
- How has Twist Bioscience Corporation's proceeds from issuance under employee stock purchase plan changed year-over-year?
- Twist Bioscience Corporation's proceeds from issuance under employee stock purchase plan increased by 3.8% year-over-year, from $1.72M to $1.78M.
- What does proceeds from issuance under employee stock purchase plan mean?
- Captures cash inflows generated from employees purchasing company shares through an Employee Stock Purchase Plan. This metric serves as a proxy for employee engagement and provides a non-dilutive source of capital that aligns staff interests with shareholder value.